The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 1.8. It has been cited 96 times, with 76 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.686
From this paper's citation signal
Citation Network Contribution
1.1
From 50 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 76 citers.
National Cancer Institute
Grant: R01CA266446
National Cancer Institute
Grant: R37CA258829
National Cancer Institute
Grant: K08CA222663
National Cancer Institute
Grant: R21CA263381
American Cancer Society
Grant: 21-104-01-IBCD
Fonds Wetenschappelijk Onderzoek
Grant: G0C530N
Fonds Wetenschappelijk Onderzoek
Grant: G070622N
Stichting Tegen Kanker
Grant: FAF-F/2018/1265
Marie Curie
Grant: 896897
Marie Curie
Grant: H2020-MSCA-IF-2019
NCI NIH HHS
Grant: R01 CA238039
NCI NIH HHS
Grant: R01 CA279268
NIH HHS
Grant: S10 OD020056
NIGMS NIH HHS
Grant: T32 GM145440
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: P01 CA163222
NCI NIH HHS
Grant: P30 CA013696
NIGMS NIH HHS
Grant: T32 GM007367
Novartis Pharmaceuticals Corporation
Vlaams Instituut voor Biotechnologie
Burroughs Wellcome Fund
KU Leuven
National Institutes of Health
FWCI
12.30
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals